³Ô¹ÏºÚÁÏ

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Patent
• Report
• Software

Filter by year:

Filter from 202120202019201820172016201520142013201220112010200920082007200620052004200320022001 to Filter to 202120202019201820172016201520142013201220112010200920082007200620052004200320022001

---

Search results

• Journal article
  Almond MH, Edwards MR, Barclay WS, Johnston SLet al., 2013,
  , THORAX, Vol: 68, Pages: 684-686, ISSN: 0040-6376
  • Cite
  • Citations: 61
• Journal article
  Shelton H, Roberts KL, Molesti E, Temperton N, Barclay WSet al., 2013,
  , JOURNAL OF GENERAL VIROLOGY, Vol: 94, Pages: 1220-1229, ISSN: 0022-1317
  • Cite
  • Citations: 59
• Journal article
  Fouchier RAM, Garcia-Sastre A, Kawaoka Y, Barclay WS, Bouvier NM, Brown IH, Capua I, Chen H, Compans RW, Couch RB, Cox NJ, Doherty PC, Donis RO, Feldmann H, Guan Y, Katz JM, Kiselev OI, Klenk HD, Kobinger G, Liu J, Liu X, Lowen A, Mettenleiter TC, Osterhaus ADME, Palese P, Peiris JSM, Perez DR, Richt JA, Schultz-Cherry S, Steel J, Subbarao K, Swayne DE, Takimoto T, Tashiro M, Taubenberger JK, Thomas PG, Tripp RA, Tumpey TM, Webby RJ, Webster RGet al., 2013,
  , SCIENCE, Vol: 339, Pages: 520-521, ISSN: 0036-8075
  • Cite
  • Citations: 24
• Journal article
  Cauldwell AV, Moncorge O, Barclay WS, 2013,
  , JOURNAL OF VIROLOGY, Vol: 87, Pages: 1278-1284, ISSN: 0022-538X
  • Cite
  • Citations: 37
• Journal article
  Moncorge O, Long JS, Cauldwell AV, Zhou H, Lycett SJ, Barclay WSet al., 2013,
  , JOURNAL OF VIROLOGY, Vol: 87, Pages: 384-394, ISSN: 0022-538X
  • Cite
  • Citations: 44
• Journal article
  Ito K, Ashcroft J, Brookes D, Cocking R, Barclay WSet al., 2013,

  Inhibitory Effects Of Rv1088, A Narrow Spectrum Kinase Inhibitor, On Cytokine Production In Response To Pandemic Flu Infections Of Primary Respiratory Cell Cultures

  , AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, Vol: 187, ISSN: 1073-449X
  • Cite
• Journal article
  Sridhar S, Begom S, Bermingham A, Ziegler T, Roberts KL, Barclay WS, Openshaw P, Lalvani Aet al., 2012,
  , EUROPEAN JOURNAL OF IMMUNOLOGY, Vol: 42, Pages: 2913-2924, ISSN: 0014-2980
  • Cite
  • Citations: 28
• Journal article
  Roberts KL, Shelton H, Stilwell P, Barclay WSet al., 2012,
  , PLOS ONE, Vol: 7, ISSN: 1932-6203
  • Cite
  • Citations: 38
• Journal article
  Shelton H, Smith M, Hartgroves L, Stilwell P, Roberts K, Johnson B, Barclay Wet al., 2012,
  , JOURNAL OF GENERAL VIROLOGY, Vol: 93, Pages: 998-1006, ISSN: 0022-1317
  • Cite
  • Citations: 16
• Journal article
  Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, GenISIS Investigators, MOSAIC Investigators, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam Pet al., 2012,
  , Nature, Vol: 484, Pages: 519-523

  The 2009 H1N1 influenza pandemic showed the speed with which a novel respiratory virus can spread and the ability of a generally mild infection to induce severe morbidity and mortality in a subset of the population. Recent in vitro studies show that the interferon-inducible transmembrane (IFITM) protein family members potently restrict the replication of multiple pathogenic viruses1, 2, 3, 4, 5, 6, 7. Both the magnitude and breadth of the IFITM proteins’ in vitro effects suggest that they are critical for intrinsic resistance to such viruses, including influenza viruses. Using a knockout mouse model8, we now test this hypothesis directly and find that IFITM3 is essential for defending the host against influenza A virus in vivo. Mice lacking Ifitm3 display fulminant viral pneumonia when challenged with a normally low-pathogenicity influenza virus, mirroring the destruction inflicted by the highly pathogenic 1918 ‘Spanish’ influenza9, 10. Similar increased viral replication is seen in vitro, with protection rescued by the re-introduction of Ifitm3. To test the role of IFITM3 in human influenza virus infection, we assessed the IFITM3 alleles of individuals hospitalized with seasonal or pandemic influenza H1N1/09 viruses. We find that a statistically significant number of hospitalized subjects show enrichment for a minor IFITM3 allele (SNP rs12252-C) that alters a splice acceptor site, and functional assays show the minor CC genotype IFITM3 has reduced influenza virus restriction in vitro. Together these data reveal that the action of a single intrinsic immune effector, IFITM3, profoundly alters the course of influenza virus infection in mouse and humans.

  • Abstract
  • Cite

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.